| A phase II study of presurgical sunitinib in patients with metastatic clear ... - UroToday |
|
|
UroToday To investigate response rate (RR) of the primary tumor after presurgical sunitinib before planned cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma (mRCC). Secondary endpoints were safety and if this strategy can be used |